Doppio-scatto qui per cambiare immagine
Infogate

For any inquiry, please address:

Federica Marotti, Ph.D.

Phone:  +39 - 06 40040358

Fax:     +39 - 06 40040364

Email:  info@explora-biotech.com  

January, 2009

The BOLALIP project is granted international funds to develop a novel drug delivery system exploiting the unique chemico-physical properties of synthetic bipolar lipids (Bolalipids).  Within the framework of the BOLALIP project, Explora will leverage its expertise in protein engineering to design and implement a biosynthetic pathways for the synthesis of functionalised isoprenic hydrocarbon chains which constitute the backbone of bolalipids.

 

December, 2008

The MAGISTER project is granted EC funds to develop  conceptually-innovative highly porous bioactive scaffolds for tissue engineering. Within the MAGISTER project, Explora will leverage its expertise in protein engineering and optimization to develop novel bioactive bio conjugates.

 

November, 2008

The ETOILE project is granted EC funds to develop a new integrated process to produce ethanol from olive oil waste waters. Within the ETOILE project Explora will collaborate to develop effective enzyme production process to exploit the biomass potential of olive oil mill waste water.

 

September, 2008

Explora S.r.l. establishes a new research unit at Venice Gateway for Science and Technology in Venice (Italy). The new research unit will be committed to the development of novel technology in the field of nanobiotechnology.

 

January, 2007

Explora S.r.l. receives public contribution for the development of a novel protein scaffold for in vitro diagnostic applications.

 

May, 2006

Explora S.r.l. receives public contribution by Tecno.Tiberis consortium for the development of an innovative methodology for protein engineering by means of in vitro recombination of nucleic acid.

 

April, 2006

Explora S.r.l and BTG S.r.l sign a technological agreement for the development and validation of a DNA microarray for the detection and characterization of nosocomial antibiotic resistance.